All presenting authors must be registered as an attendee at IgNS 2019 Conference.

Before submitting your abstract please read the following submission guidelines:

1. All abstracts are required to convey relevance to the IgNS mission, vision and values. IgNS is dedicated to advancing the practice of nursing and pharmacy in education, management, clinical practice, and research fields of immunoglobulin (Ig) therapy.

2. Abstracts should contain original research and not be promotional in nature.  IgNS accepts encore presentations of significant original work from other healthcare conferences.  These must have been published within the past 12 months.

3. Abstract content should fit one of the following five categories:

  • Case studies
  • Original research and results (clinical, healthcare economics, basic science, etc.)
  • Evidenced-based practice
  • Clinical innovations
  • Performance improvement

4. Abstract word count: 500 or less (not including section headers).

5. Abstracts are not edited for content; therefore, double-check your abstract for typographical or grammatical errors before submitting.

6. Prepare abstracts to include the following key section:

  • Title
  • Author and affiliation block
  • Introduction (Background and Purpose)
  • Methods
  • Results
  • Discussion
  • Conclusion

7. Disclosures of financial support and/or study sponsorship must be made clearly.

8. Acceptance is determined by adequately meeting submission criteria and must convey relevance to IgNS.

  • Title
    • Should be a concise summary of the abstract itself
    • Does not include brand names or abbreviations
    • May be written in the form of a question
  • Author block
    • Includes name, credentials, and employer/institutional affiliation
    • When authors all work for the same employer, the employer or institutional name is listed at the end of the authors
    • When authors work for different employers, superscript should be used to designate which author is associated with which employer/institution
  •  Introduction
    • Describes problem or challenge
    • Provides context or historical perspective for problem, issue, or case being presented
    • Clearly states the hypothesis
    • Utilizes literature/research or industry best practice where appropriate to support the need for new idea
    • References your own organization as “this provider” or “this organization”
    • Does not reference brand or proprietary names
  • Methods
    • Describes concise overview of steps taken to improve clinical practice or outcomes and those actions take for data collection
    • Where appropriate the population should be expanded on (total participants, gender, age, diagnoses) and how inclusion or exclusion is determined
    • Represents a sample size sufficient to support findings
    • Describes or quantifies how successful outcomes are able to be determined
    • Includes statistics where appropriate such as cost impact
    • Includes the timeline data was collected or research took place
    • References your own organization as “this provider” or “this organization”
    • Does not reference brand or proprietary names
  • Results
    • Provides quantifiable results where applicable
    • Alludes to whether hypothesis was proved or disproved
    • Is presented in narrative fashion, saving all visual elements for the poster
    • Describes results in sufficient detail to support conclusion
    • References your own organization as “this provider” or “this organization”
    • Does not reference brand or proprietary names
  • Discussion
    • Describes lesson(s) learned from project/study
    • All statements are supported by data in the Results section
    • Addresses any implications for future application
    • References your own organization as “this provider” or “this organization”
    • Does not reference brand or proprietary names
  • Conclusion
    • A short statement that is supported by Results section
    • Is written using proper grammar, punctuation, and spelling
    • References your own organization as “this provider” or “this organization”
    • Does not reference brand or proprietary names

9. Brand Names

  • Use of brand name are allowed once within the abstract and on the poster
  • Use of brand name may only be used in the Methods section.
  • Organization names are considered brand names and may only be placed in the Author section
    • Within the body of the poster then refer to the organization in generic terms
      • Example: “Home infusion pharmacy”